243 results
Responsible body
PRAC Remove PRAC filter
Type of content
News Remove News filter
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023
PRAC, Last updated: 22/05/2023 -
List item
News: EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
PRAC, Last updated: 03/11/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
News: Call for expressions of interest for civil society representatives to participate in work of EMA
PRAC, Last updated: 27/10/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
PRAC, Last updated: 17/09/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
News: Call for independent scientific experts to join EMA's Pharmacovigilance Risk Assessment Committee (PRAC) - deadline extended
PRAC, Last updated: 20/11/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 September 2018
PRAC, Last updated: 07/09/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 July 2018
PRAC, Last updated: 13/07/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 June 2018
PRAC, Last updated: 15/06/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 14-17 May 2018
PRAC, Last updated: 18/05/2018 -
List item
Press release: EMA review of Zinbryta confirms medicine's risks outweigh its benefits
PRAC, Last updated: 18/05/2018 -
List item
Press release: PRAC recommends new measures to minimise risk of rare but serious liver injury with Esmya for fibroids
PRAC, Last updated: 18/05/2018 -
List item
Press release: New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir
PRAC, Last updated: 18/05/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 April 2018
PRAC, Last updated: 13/04/2018 -
List item
Press release: EMA reviewing risk of dosing errors with methotrexate
PRAC, Last updated: 13/04/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 March 2018
PRAC, Last updated: 09/03/2018 -
List item
Press release: Prostate cancer medicine Xofigo must not be used with Zytiga and prednisone/prednisolone
PRAC, Last updated: 09/03/2018 -
List item
Press release: EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders
PRAC, Last updated: 02/03/2018 -
List item
Press release: PRAC recommends new measures to avoid valproate exposure in pregnancy
PRAC, Last updated: 09/02/2018 -
List item
Press release: Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing
PRAC, Last updated: 09/02/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 February 2018
PRAC, Last updated: 09/02/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 January 2018
PRAC, Last updated: 12/01/2018 -
List item
Press release: PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market
PRAC, Last updated: 12/01/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2017
PRAC, Last updated: 01/12/2017